Market Overview

UPDATE: Morgan Stanley Reiterates On CIGNA As 4Q Issues May Linger

Related CI
Bank Of America Raises Price Targets On Managed Care Companies
How Different Companies Are Tackling The Affordable Care Act
Making Money With Charles Payne: 11/24/14 (Fox Business)

In a report published Friday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating on CIGNA (NYSE: CI), but lowered the price target from $100.00 to $93.00.

In the report, Morgan Stanley noted, “Issues CI experienced in 4Q may spill over into 2014 results. However, >$1.5B in deployable cash in FY14 and improvements in 2H14 should yield mid single-digit EPS growth. Our adjusted EPS of $7.16 reflects 6% Y/Y growth off a lower 2013 platform.”

CIGNA closed on Friday at $76.14.

Latest Ratings for CI

DateFirmActionFromTo
Nov 2014Bank of AmericaMaintainsBuy
Nov 2014BarclaysMaintainsEqual-weight
Oct 2014CitigroupMaintainsNeutral

View More Analyst Ratings for CI
View the Latest Analyst Ratings

Posted-In: Andrew Schenker Morgan StanleyAnalyst Color Price Target Analyst Ratings

 

Related Articles (CI)

Around the Web, We're Loving...

Get Benzinga's Newsletters